It's been and interesting and diverse week in the field of pharmaceuticals and health with articles that cover a broad range of topics.
Here are some of the ones that I found more intesesting and informative:
- Researchers ID Traits of Aggressive Prostate Cancer (HealthDay)
- Diabetes, Heart Risk Lower with Newer Antipsychotic (Reuters Health)
- Erectile Dysfunction an Indicator of Men's Health (HealthDay)
- 'Standard' Glucose Test May Be Wrong One for Obese Children (HealthDay)
- Research Shows Why Statins Don't Work for Everyone (HealthDay)
- Cymbalta Approved for Fibromyalgia (HealthDay)
- Testosterone Gel Benefits Some Men with Diabetes (Reuters Health)
- FDA Approves Diaphragm-Pacing Device (Food and Drug Administration)
- FDA Panel Recommends Enbrel for Pediatric Patients (HealthDay)
- Bone Drug Works for Breast Cancer Survivors (Reuters Health)
- Brain Activity May Predict Schizophrenia Behavior (HealthDay)
- Cancer Drug Gleevec Linked to Muscle Damage (HealthDay)
- Potential Exposure to Lead in Artificial Turf (Centers for Disease Control and Prevention)
- Drug Effective against Heart-Lung Disorder (HealthDay)
- 32000 Vets To Be Warned About Suicide-Linked Drug Chantix (ABC News)
Hope you find something of interest to you! Enjoy!
Comment Preview